UCLA Semel institute — Los Angeles, California

UCLA Semel institute is a clinical research site located in Los Angeles, California, United States 90024.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Semel institute has participated in 1 clinical trials.

Therapeutic areas: Obsessive Compulsive Disorder.

Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Semel institute?

UCLA Semel institute has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Semel institute conducted?

UCLA Semel institute has 1 clinical trials on record. Their work covers Obsessive Compulsive Disorder.

Is UCLA Semel institute accredited by Crixeo Health?

UCLA Semel institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Semel institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.